Latest Avidity Partners Management LP Stock Portfolio
$3.10Billion– No. of Holdings #87
Avidity Partners Management LP Performance:
2024 Q1: 9.55%YTD: 9.55%2023: 8.03%
Performance for 2024 Q1 is 9.55%, and YTD is 9.55%, and 2023 is 8.03%.
About Avidity Partners Management LP and 13F Hedge Fund Stock Holdings
Avidity Partners Management LP is a hedge fund based in DALLAS, TX. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $9.2 Billions. In it's latest 13F Holdings report, Avidity Partners Management LP reported an equity portfolio of $3.1 Billions as of 31 Mar, 2024.
The top stock holdings of Avidity Partners Management LP are FUSN, BSX, ARVN. The fund has invested 4.5% of it's portfolio in FUSION PHARMACEUTICALS INC and 4.3% of portfolio in BOSTON SCIENTIFIC CORP.
The fund managers got completely rid off KARUNA THERAPEUTICS INC (KRTX), IMMUNOGEN INC (IMGN) and ZOETIS INC (ZTS) stocks. They significantly reduced their stock positions in BIOHAVEN LTD, THERMO FISHER SCIENTIFIC INC (TMO) and MCKESSON CORP (MCK). Avidity Partners Management LP opened new stock positions in THE CIGNA GROUP (CI), MERCK & CO INC (MRK) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES INC (RVMD), INTUITIVE SURGICAL INC (ISRG) and DIANTHUS THERAPEUTICS INC.
The top stock holdings of Avidity Partners Management LP are FUSN, BSX, ARVN. The fund has invested 4.5% of it's portfolio in FUSION PHARMACEUTICALS INC and 4.3% of portfolio in BOSTON SCIENTIFIC CORP.
The fund managers got completely rid off KARUNA THERAPEUTICS INC (KRTX), IMMUNOGEN INC (IMGN) and ZOETIS INC (ZTS) stocks. They significantly reduced their stock positions in BIOHAVEN LTD, THERMO FISHER SCIENTIFIC INC (TMO) and MCKESSON CORP (MCK). Avidity Partners Management LP opened new stock positions in THE CIGNA GROUP (CI), MERCK & CO INC (MRK) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES INC (RVMD), INTUITIVE SURGICAL INC (ISRG) and DIANTHUS THERAPEUTICS INC.
Avidity Partners Management LP Equity Portfolio Value
Last Reported on: 15 May, 2024
Avidity Partners Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Avidity Partners Management LP made a return of 9.55% in the last quarter. In trailing 12 months, it's portfolio return was 27.94%.
New Buys
| Ticker | $ Bought |
|---|---|
| the cigna group | 67,008,600 |
| merck & co inc | 66,238,900 |
| cg oncology inc | 63,864,200 |
| illumina inc | 63,730,200 |
| alpine immune sciences inc | 46,565,100 |
| alnylam pharmaceuticals inc | 36,316,400 |
| regenxbio inc | 27,392,300 |
| apogee therapeutics inc | 25,576,100 |
New stocks bought by Avidity Partners Management LP
Additions
| Ticker | % Inc. |
|---|---|
| revolution medicines inc | 958 |
| intuitive surgical inc | 165 |
| dianthus therapeutics inc | 123 |
| immunovant inc | 106 |
| avantor inc | 27.01 |
| lantheus hldgs inc | 26.32 |
| surgery partners inc | 23.94 |
| align technology inc | 21.31 |
Additions to existing portfolio by Avidity Partners Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| biohaven ltd | -93.47 |
| thermo fisher scientific inc | -79.96 |
| mckesson corp | -61.05 |
| danaher corporation | -50.41 |
| vaxcyte inc | -50.19 |
| ideaya biosciences inc | -47.39 |
| privia health group inc | -40.62 |
| rocket pharmaceuticals inc | -40.38 |
Avidity Partners Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| immunogen inc | -54,236,200 |
| compass therapeutics inc | -2,495,380 |
| travere therapeutics inc | -7,434,820 |
| verona pharma plc | -15,524,300 |
| arrowhead pharmaceuticals in | -21,848,400 |
| crinetics pharmaceuticals in | -18,821,800 |
| intellia therapeutics inc | -13,642,300 |
| cerevel therapeutics hldng i | -11,740,100 |
Avidity Partners Management LP got rid off the above stocks
Sector Distribution
Avidity Partners Management LP has about 83.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 83.9 |
| Others | 13.7 |
| Basic Materials | 2.4 |
Market Cap. Distribution
Avidity Partners Management LP has about 41% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 34.5 |
| MID-CAP | 27.8 |
| SMALL-CAP | 14.4 |
| UNALLOCATED | 13.7 |
| MEGA-CAP | 6.5 |
| MICRO-CAP | 3.2 |
Stocks belong to which Index?
About 57.2% of the stocks held by Avidity Partners Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 42.9 |
| RUSSELL 2000 | 29.2 |
| S&P 500 | 28 |
Avidity Partners Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Avidity Partners Management LP
Avidity Partners Management LP has 87 stocks in it's portfolio. About 30.1% of the portfolio is in top 10 stocks. ANTX proved to be the most loss making stock for the portfolio. FUSN was the most profitable stock for Avidity Partners Management LP last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABBV | abbvie inc | 1.33 | 227,000 | 41,336,700 | reduced | -20.18 | ||
| ACAD | acadia pharmaceuticals inc | 0.35 | 588,500 | 10,881,400 | new | |||
| ACHC | acadia healthcare company in | 2.57 | 1,005,000 | 79,616,100 | reduced | -13.11 | ||
| ACIU | ac immune sa | 0.43 | 4,470,000 | 13,231,200 | added | 0.02 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALGN | align technology inc | 2.00 | 189,000 | 61,976,900 | added | 21.31 | ||
| ALNY | alnylam pharmaceuticals inc | 1.17 | 243,000 | 36,316,400 | new | |||
| ALPN | alpine immune sciences inc | 1.50 | 1,174,700 | 46,565,100 | new | |||
| AMLX | amylyx pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANTX | an2 therapeutics inc | 0.12 | 1,150,000 | 3,737,500 | added | 0.88 | ||
| ARGX | argenx se | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 3.97 | 2,985,190 | 123,229,000 | added | 0.00 | ||
| ARWR | arrowhead pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.45 | 982,000 | 13,821,600 | new | |||
| AVTR | avantor inc | 2.22 | 2,695,000 | 68,911,200 | added | 27.01 | ||
| AXSM | axsome therapeutics inc | 1.11 | 431,000 | 34,393,800 | reduced | -6.18 | ||
| AZN | astrazeneca plc | 0.35 | 160,000 | 10,840,000 | new | |||
| BDX | becton dickinson & co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BPMC | blueprint medicines corp | 1.30 | 426,000 | 40,410,400 | reduced | -30.73 | ||